CRMD

CorMedix Inc.

Price

$8.52

return (12m)

-34.76%

p/e

3.24

p/bv

1.32

DIVIDEND YIELD

0.00%

CRMD price

CorMedix

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment CRMD

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

7.78%

3 months

5.71%

1 year

-34.76%

2 years

65.12%

5 years

39.22%

10 years

0.83%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals CRMD

Valuation

P/E

3.24

Sector -2.19

Industry 1.21

P/BV

1.32

Sector 2.22

Industry 2.11

P/Revenue (PSR)

1.32

Sector 2.01

Industry 0.78

EV/EBITDA

9.27

Sector -17.81

Industry -25.30

EV/EBIT

11.54

Sector -26.72

Industry -18.04

P/EBITDA

2.39

Sector 0.36

Industry 0.18

P/EBIT

2.78

Sector -3.34

Industry 1.26

P/Total Assets

0.67

Sector 1.23

Industry 0.86

P/Net Current Assets

16.26

Sector -27.35

Industry -12.37

P/Working Capital

2.07

Sector -4.54

Industry -49.48

EPS

2.40

Sector -0.87

Industry -0.55

BVPS

5.91

Sector 3.80

Industry 5.36

Efficiency

Gross Margin

82.68%

Sector 43.36%

Industry 31.53%

EBITDA Margin

53.82%

Sector -323.65%

Industry -73.39%

EBIT Margin

43.21%

Sector -194.57%

Industry -11.94%

Operating Margin

47.22%

Sector -24.37%

Industry -9.87%

Net Profit Margins

40.72%

Sector -28.88%

Industry -19.76%

Asset Turnover

0.11

Sector 0.12

Industry 0.22

Profitability

ROE

40.62%

Sector -33.82%

Industry -37.56%

ROA

20.70%

Sector -29.63%

Industry -17.56%

ROIC

23.33%

Sector -431.16%

Industry -111.59%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

2.56

Sector 1.84

Industry 1.14

Net Debt / EBITDA

-2.09

Sector -1.47

Industry -31.86

Net Debt / EBIT

-2.60

Sector -1.32

Industry 2.06

Net Debt / Equity

-0.24

Sector -0.35

Industry 0.14

Gross Debt / Equity

0.31

Sector 0.14

Industry 0.51

Equity/Assets

0.51

Sector 0.42

Industry 0.25

Liabilities/Assets

0.49

Sector 0.46

Industry 0.46

Growth

5Y Revenue CAGR

370.19%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

FAIR VALUE OF CorMedix ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$8.52

Fair Value

$17.86

Upside Return potential.

109.68%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals CRMD

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
CRMD CorMedix Inc.	$8.52	-34.96%	0.00%	3.24	1.32	40.62%	40.72%
LLY Eli Lilly and Compay	$1,280.34	83.05%	0.54%	39.62	31.24	78.84%	33.53%
ISRG Intuitive Surgical Inc.	$397.72	-17.36%	0.00%	45.09	7.73	17.15%	28.45%
SNY Sanofi	$45.83	-4.42%	4.04%	7.10	1.31	18.43%	13.81%
NVS Novartis AG	$160.31	31.78%	2.05%	22.57	6.87	30.41%	22.50%
TMO Thermo Fisher Scientific Inc.	$613.54	26.39%	0.30%	31.58	4.17	13.19%	15.04%
ABT Abbott Laboratories	$114.43	-11.62%	2.33%	33.60	3.57	10.61%	11.65%
MDT Medtronic PLC	$94.13	4.71%	3.10%	24.50	2.35	9.59%	13.20%
GSK GlaxoSmithKline PLC	$52.88	41.51%	3.59%	15.15	4.28	28.24%	14.54%
CVS CVS Health Corporation	$93.65	37.68%	2.73%	25.48	1.56	6.12%	1.18%
BSX Boston Scientific Corp.	$52.01	-49.87%	0.00%	18.98	0.00	-%	19.57%
TMDX TransMedics Group Inc.	$93.97	-25.21%	0.00%	20.36	5.96	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$562.20	-11.86%	0.00%	38.32	27.08	70.67%	25.03%
RMD ResMed Inc.	$230.65	-18.34%	1.07%	21.40	4.95	23.13%	26.94%
DHR Danaher Corporation	$211.50	0.79%	0.71%	35.81	2.73	7.61%	15.95%
HCA HCA Healthcare Inc.	$407.05	4.09%	0.74%	13.12	-27.97	-213.15%	8.77%
COHR Coherent Inc.	$287.47	217.68%	0.00%	79.32	5.68	7.16%	11.31%
PHG Koninklijke Philips NV	$27.62	4.58%	3.70%	20.19	1.98	9.80%	6.30%
SYK Stryker Corp.	$339.98	-9.77%	1.02%	34.97	5.44	15.55%	14.43%
INMD InMode Ltd.	$15.04	5.14%	0.00%	11.54	1.42	12.32%	20.69%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

CRMD Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT CorMedix

CorMedix Inc.

Average Investor10 user rating

4.0 (6 people)

United States

20 years

Founded: 2006

2010

Time since IPO - 16 years

35

Employees

CorMedix Inc. (United States) is listed on the Nasdaq and has a market capitalization of $606.84 million, with shareholders equity totaling $460.83 million.

The company employs approximately 35 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, CorMedix Inc. reported $459.64 million in revenue, generating net income of $187.17 million.

Key financial metrics include a P/E ratio of 3.24, a price-to-book (P/B) ratio of 1.32, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker CRMD.

Market cap

$606.84 million

Net worth

$460.83 million

$460,830,000.00

Assets

$904.05 million

$904,050,000.00

Total Shares Outstanding

78.00 million

78,000,000

Average Daily Trading Volume

$1.33 million

$1,326,280.00

Sector

Health

Industry

Pharmaceutical Products

CRMD

CRMD revenue and profits

Financial Results CRMD

DRAG THE FRAME TO SEE MORE DATA

CRMD cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$93.65 36,41% (12M)

P/E

25.48

2.73%

ROE

6.12%

P/BV

1.56

CI - Cigna

$277.45 --6,37% (12M)

P/E

10.82

2.19%

ROE

16.04%

P/BV

1.74

CNC - Centene

$64.69 120,03% (12M)

P/E

-6.48

0.00%

ROE

-22.51%

P/BV

1.46

HUM - Humana

$378.02 32,24% (12M)

P/E

36.20

0.92%

ROE

6.63%

P/BV

2.40

SNY - Sanofi

$45.83 --5,73% (12M)

P/E

7.10

4.04%

ROE

18.43%

P/BV

1.31

LLY - Eli Lilly

$1,280.34 81,92% (12M)

P/E

39.62

0.54%

ROE

78.84%

P/BV

31.24

HCA - HCA Healthcare

$407.05 --0,11% (12M)

P/E

13.12

0.74%

ROE

-213.15%

P/BV

-27.97

NVS - Novartis

$160.31 28,43% (12M)

P/E

22.57

2.05%

ROE

30.41%

P/BV

6.87